Senior insider sale
SVP, CHIEF OPERATING OFFICER at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$4.30M
41.70K shares
What this filing means
CAUDILL CORTNEY plans to sell 41.70K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $4.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2026ACC: 0001950047-26-007986
Officer· SVP, CHIEF OPERATING OFFICER
Since Feb 2026
41.70K
Shares to sell
$4.30M
Approx. market value
41.70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
8/11/2026
32.66KStock Option Exercise
Cash
8/11/2026
3.77KStock Option Exercise
Cash
8/11/2026
5.28KTotal acquired41.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2026 | Stock Option Exercise Cash | 32.66K | — |
8/11/2026 | Stock Option Exercise Cash | 3.77K | — |
8/11/2026 | Stock Option Exercise Cash | 5.28K | — |
| Total | 41.70K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
41.70K
Market value
$4.30M
8/11/2026
Total
Units
41.70K
Value
$4.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/11/2026 | 41.70K | $4.30M | NASDAQ | Planned |
| Total | 41.70K | $4.30M | ||